FDA Approved: CLOBAZAM — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved a supplemental application for CLOBAZAM (clobazam) from NorthStar RxLLC under ANDA 209796, confirming its status as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)